Latest Breaking News On - Ddiscovery biology - Page 1 : comparemela.com

Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease

MRT-6160, a VAV1-directed molecular glue degrader , inhibits colitis disease progression and colon inflammation, lowers inflammatory mucosal cytokines, and reduces expression of IBD-associated genes.

United statesCory trombleeMonte rosaAndrew funderburkMarkus warmuthMonte rosa quMarisa pelusoExchange commissionCompany quCompany mgdsGlobenewswire incMonte rosa therapeutics incRosa therapeuticsDigestive disease weekT andb cellChief executive officer

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesMark littonSharay settiHans moebiusRachel leningtonSherif redaAthira pharmaJulie rathbunAlzheimer association international congressMotor neurone disease associationSociety for neuroscience sfn annual meetingSecurities exchangeInternational symposiumExchange commissionClinical development pipeline programsDevelopment rd expenses

Inflammation Specialist Named New Centre Head at Hudson Institute

Inflammation Specialist Named New Centre Head at Hudson Institute
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Elizabeth hartlandNational healthResearch councilEliza hall instituteInfectious diseases hudson instituteAutoinflammatory disease laboratoryViertel foundationHudson instituteCentre for innate immunityUniversity of melbourneProfessor seth mastersInnate immunityInfectious diseasesSeth mastersCentre headProf masters

As obesity drugs soar, Mass biotechs seek a slice of the market

Several biotechs in Mass. are seeking to elbow their way into the lucrative market, which is currently dominated by Denmark’s Novo Nordisk, which makes Wegovy and Ozempic, and Eli Lilly, which produces Mounjaro.

United kingdomUnited statesLotte bjerre knudsenLeslie cortesLilly skovronskyDaniel skovronsky lillyJoel habenerCarsten snejbjerg bloombergTimothy springerNovo nordiskHarith rajagopalanNovo ozempicDavid meekerJay backstromLin quekSam nicholls

Specific Biologics Announces Additional Investment and Appointment of Experienced Biotechnology Leader Steven Kanner, PhD, to the Board of Directors

Specific Biologics Announces Additional Investment and Appointment of Experienced Biotechnology Leader Steven Kanner, PhD, to the Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaSteven kannerAgensys astellas pharmaNikhil thatteBristol myers squibbDaniel hetuCystic fibrosis foundationUniversity of californiaUniversity of miami miller school medicineUniversity of virginia department microbiologyArrowhead pharmaceuticalsDiscovery biology at arrowhead pharmaceuticalsBiologics incAstex pharmaceuticalsSpecific biologics